INHA and tuberculosis: InhA can be targeted as anti-TB drugs, including indirect inhibitors (Inh, ethionicotinamide, prothionamide) and direct inhibitors (triclosan/diphenyl ether, pyrrolidine formamide, pyrrole, acetamide, thiadiazole, triazole) (43).